Keywords
antibody, antibody-based therapeutic, antibody-fusion protein, anticytokine inhibitors, biologics, interleukin-1, interleukin-12, interleukin-17, interleukin-23, interleukin-6, immunosuppression, pregnancy, teratogenicity, tumor necrosis factor alpha, transplacental antibody transfer, vertical transmission of immunity